Relationship between antimicrobial susceptibility and highly active β-lactamases in Pseudomonas aeruginosa
Wen Jingyun
Abstract
Wen Jingyun
Abstract
Objective To investigate the antimicrobial resistance and the prevanlence of production of AmpC β-lactamases,extended-spectrum β-lactamases(ESBLs)and metallo β-lactamases(MBLs)in Pseudomonas aeruginosa(P.aeruginosa)clinical isolates,for guiding the rational use of antibiotics. Methods Antimicrobial susceptibility tests were done by Kirby-Bauer disk diffusions method,the phenotypes of P.aeruginosa strains harboring AmpC β-lactamases and /or ESBLs were detected by modified three-dimensional extract test,while MBLs were identified using MBL E-test strips. Results The susceptibility rate of 186 P.aeruginosa clinical isolates to imipenem was the highest about 82.3%,as to ciprofloxacin,piperacillin/tazobactam,ceftazidime,amikacin,cefoperazone/sulbactam were 75.3%,74.2%,72.6%,71.0%,70.4% respectively,but to ticarcillin,cefoperazone,aztreonam were no more than 60%.The resistant rates to cefotaxime and ceftriaxone were 61.8% and 55.9% respectively.AmpC β-lactamases,Amcp β-lactamases combined with ESBLs,ESBLs and MBLs producing strains were detected in 8.6%,2.7%,14.5% and 4.8% of P.aeruginosa respectively. Conclusion The resistant phenomenon of P.aeruginosa clinical isolates should not be ignored,production of highly active β-lactamases is one of resistant mechanisms in P.aeruginosa,imipenem is still the best choice for treating infection caused by P.aeruginosa.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the antimicrobial resistance and the prevanlence of production of AmpC β-lactamases,extended-spectrum β-lactamases(ESBLs)and metallo β-lactamases(MBLs)in Pseudomonas aeruginosa(P.aeruginosa)clinical isolates,for guiding the rational use of antibiotics. Methods Antimicrobial susceptibility tests were done by Kirby-Bauer disk diffusions method,the phenotypes of P.aeruginosa strains harboring AmpC β-lactamases and /or ESBLs were detected by modified three-dimensional extract test,while MBLs were identified using MBL E-test strips. Results The susceptibility rate of 186 P.aeruginosa clinical isolates to imipenem was the highest about 82.3%,as to ciprofloxacin,piperacillin/tazobactam,ceftazidime,amikacin,cefoperazone/sulbactam were 75.3%,74.2%,72.6%,71.0%,70.4% respectively,but to ticarcillin,cefoperazone,aztreonam were no more than 60%.The resistant rates to cefotaxime and ceftriaxone were 61.8% and 55.9% respectively.AmpC β-lactamases,Amcp β-lactamases combined with ESBLs,ESBLs and MBLs producing strains were detected in 8.6%,2.7%,14.5% and 4.8% of P.aeruginosa respectively. Conclusion The resistant phenomenon of P.aeruginosa clinical isolates should not be ignored,production of highly active β-lactamases is one of resistant mechanisms in P.aeruginosa,imipenem is still the best choice for treating infection caused by P.aeruginosa.
Key concepts: Cefoperazone, Aztreonam, Ticarcillin, Pseudomonas aeruginosa, Microbiology, Piperacillin, Imipenem, Sulbactam